Jane H. Bentley

2.4k total citations · 1 hit paper
20 papers, 1.7k citations indexed

About

Jane H. Bentley is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Jane H. Bentley has authored 20 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Physiology. Recurrent topics in Jane H. Bentley's work include Eosinophilic Disorders and Syndromes (6 papers), Urticaria and Related Conditions (6 papers) and Asthma and respiratory diseases (6 papers). Jane H. Bentley is often cited by papers focused on Eosinophilic Disorders and Syndromes (6 papers), Urticaria and Related Conditions (6 papers) and Asthma and respiratory diseases (6 papers). Jane H. Bentley collaborates with scholars based in United States, United Kingdom and France. Jane H. Bentley's co-authors include David A. Morrow, James A. de Lemos, Christopher P. Cannon, Carolyn H. McCabe, Christian Hall, Marc S. Sabatine, Eugene Braunwald, Torbjørn Omland, Carolyn H. McCabe and Robert G. Wilcox and has published in prestigious journals such as New England Journal of Medicine, Journal of Allergy and Clinical Immunology and The American Journal of Cardiology.

In The Last Decade

Jane H. Bentley

19 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary Syndromes

2001 991 citations James A. de Lemos, David A. Morrow et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Jane H. Bentley

Since Specialization

Citations

This map shows the geographic impact of Jane H. Bentley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane H. Bentley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane H. Bentley more than expected).

Fields of papers citing papers by Jane H. Bentley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane H. Bentley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane H. Bentley. The network helps show where Jane H. Bentley may publish in the future.

Co-authorship network of co-authors of Jane H. Bentley

This figure shows the co-authorship network connecting the top 25 collaborators of Jane H. Bentley. A scholar is included among the top collaborators of Jane H. Bentley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane H. Bentley. Jane H. Bentley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype 2023 ·ACR Open Rheumatology ·Benjamin Terrier, David Jayne, Bernhard Hellmich, Jane H. Bentley, Jonathan Steinfeld, Steven W. Yancey, Namhee Kwon, Praveen Akuthota, Paneez Khoury, (unknown), Michael E. Wechsler, (unknown)	13
2	Mepolizumab has clinical benefits including oral corticosteroid sparing irrespective of baseline EGPA characteristics 2023 ·ERJ Open Research ·David Jayne, Benjamin Terrier, Bernhard Hellmich, Paneez Khoury, (unknown), Jane H. Bentley, Jonathan Steinfeld, Steven W. Yancey, Namhee Kwon, Michael E. Wechsler, Praveen Akuthota	10
3	Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndrome 2023 ·Frontiers in Medicine ·Florence Roufosse, Joseph H. Butterfield, Jonathan Steinfeld, Jane H. Bentley, Robyn von Maltzahn, Namhee Kwon, Linda Nelsen	6
4	Characterization of disease flares and impact of mepolizumab in patients with hypereosinophilic syndrome 2022 ·Frontiers in Immunology ·Fabrizio Pane, Guillaume Lefèvre, Namhee Kwon, Jane H. Bentley, Steven W. Yancey, Jonathan Steinfeld	4
5	PSY2 Impact of Mepolizumab on Health-Related Quality of Life in Patients With Hypereosinophilic Syndrome 2021 ·Value in Health ·Robyn von Maltzahn, Linda Nelsen, Jane H. Bentley, Namhee Kwon, Jonathan Steinfeld	1
6	Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial 2020 ·Journal of Allergy and Clinical Immunology ·Florence Roufosse, Jean‐Emmanuel Kahn, Marc E. Rothenberg, Andrew J. Wardlaw, Amy D. Klion, Suyong Yun Kirby, M Gilson, Jane H. Bentley, Eric Bradford, Steven W. Yancey, Jonathan Steinfeld, Gerald J. Gleich	111
7	PNS231 THE VALUE OF EMBEDDED INTERVIEWS: CASE STUDY OF QUALITATIVE AND QUANTITATIVE ASSESSMENT OF THE PATIENT EXPERIENCE OF MEPOLIZUMAB SELF-ADMINISTRATION 2019 ·Value in Health ·(unknown), Richard Follows, Jane H. Bentley, (unknown), (unknown), (unknown), Robyn von Maltzahn	0
8	The Pharmacokinetics and Relative Bioavailability of Mepolizumab 100 mg Liquid Formulation Administered Subcutaneously to Healthy Participants: A Randomized Trial 2019 ·Clinical Pharmacology in Drug Development ·Shaila Shabbir, Isabelle Pouliquen, Jane H. Bentley, Eric Bradford, Morrys C. Kaisermann, Muna Albayaty	14
9	Self-Administration of Mepolizumab Liquid Using a Single-Use Prefilled Autoinjector 2019 ·Kenneth R. Chapman, David I. Bernstein, Ian Pavord, Richard Follows, Jane H. Bentley, Isabelle Pouliquen, Eric Bradford	1
10	Mepolizumab Prefilled Autoinjector and Prefilled Syringe Real World Use: The Patient Experience 2019 ·(unknown), Richard Follows, Jane H. Bentley, (unknown), (unknown), (unknown), Robyn von Maltzahn	2
11	The Pharmacokinetics and Relative Bioavailability of Mepolizumab 100 mg Liquid Formulation Administered Subcutaneously to Healthy Participants: A Randomized Trial 2019 ·(unknown), Isabelle Pouliquen, Jane H. Bentley, Eric Bradford, (unknown), Muna Albayaty	1
12	Usability of mepolizumab single-use prefilled syringe for patient self-administration 2019 ·Journal of Asthma ·Elisabeth H. Bel, David I. Bernstein, Leif Bjermer, Richard Follows, Jane H. Bentley, Isabelle Pouliquen, Eric Bradford	29
13	Usability of mepolizumab single-use prefilled autoinjector for patient self-administration 2019 ·Journal of Asthma ·David I. Bernstein, Ian Pavord, Kenneth R. Chapman, Richard Follows, Jane H. Bentley, Isabelle Pouliquen, Eric Bradford	24
14	Self-Administration of Mepolizumab Liquid Using a Single-Use Prefilled Syringe 2019 ·Eric Bradford, Daniel Bernstein, Leif Bjermer, Richard Follows, Jane H. Bentley, Isabelle Pouliquen, Elisabeth H. Bel	1
15	Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study 2015 ·The Lancet Respiratory Medicine ·Gísli Jenkins, Juliet K. Simpson, Gauri Saini, Jane H. Bentley, Anne‐Marie Russell, Rebecca Braybrooke, Philip L. Molyneaux, Tricia M. McKeever, Athol U. Wells, Aiden Flynn, Richard Hubbard, Diana Julie Leeming, Richard P. Marshall, M.A. Karsdal, Pauline T. Lukey, Toby M. Maher	198
16	The effect of GSK2190915, a 5-lipoxygenase‐activating protein inhibitor, on exercise-induced bronchoconstriction 2014 ·Allergy and Asthma Proceedings ·(unknown), Jane H. Bentley, David Miller, Richard K. Sterling, (unknown), Martha Tarpay, David S. Pearlman, Virginia Norris	6
17	Does initial and delayed heart rate predict mortality in patients with acute coronary syndromes? 2004 ·Clinical Cardiology ·David R. Kovar, Christopher P. Cannon, Jane H. Bentley, Andrew Charlesworth, William J. Rogers	59
18	The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes 2002 ·ACC Current Journal Review ·James A. de Lemos, David A. Morrow, Jane H. Bentley	110
19	The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary Syndromes breakdown → 2001 ·New England Journal of Medicine ·James A. de Lemos, David A. Morrow, Jane H. Bentley, Torbjørn Omland, Marc S. Sabatine, Carolyn H. McCabe, Christian Hall, Christopher P. Cannon, Eugene Braunwald	991
20	Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris 2001 ·The American Journal of Cardiology ·Christopher P. Cannon, Carolyn H. McCabe, Robert G. Wilcox, Jane H. Bentley, Eugene Braunwald	166

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact